Closed IV Spikes Market to Reach USD 760 Million by 2036, Growing at 8.5% CAGR as Safe Infusion Practices and Closed Transfer Technologies Become Standard Healthcare Priorities

The global Closed IV Spikes Market is projected to grow from USD 335 million in 2026 to USD 760 million by 2036, registering a steady 8.5% CAGR during the 2026-2036 forecast period. The market was valued at USD 310 million in 2025 and is expected to create an absolute opportunity of USD 425 million by 2036.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15411

The market's growth reflects the increasing adoption of closed transfer technologies, rising emphasis on infection prevention, expanding oncology treatment volumes, and growing demand for sterile medication preparation. Healthcare providers worldwide are investing in safer infusion systems that reduce contamination risk, improve medication handling, and support compliance with evolving clinical safety standards.

Key Market Highlights at a Glance

• Market size in 2025: USD 310 million
• Market size in 2026: USD 335 million
• Forecast market size by 2036: USD 760 million
• Forecast period: 2026-2036
• CAGR: 8.5%

• Absolute opportunity by 2036: USD 425 million
• Leading spike type: Closed Spikes (35.0% share in 2026)
• Leading safety feature: Needle-Free Systems (33.0% share in 2026)
• Leading fluid type: IV Fluids (39.0% share in 2026)
• Leading end user: Hospitals (58.0% share in 2026)
• Fastest-growing major country: United States (8.9% CAGR)

• Key countries analyzed:
o United States
o Germany
o Japan
o China
o South Korea

The Closed IV Spikes Market is forecast to expand from USD 335 million in 2026 to USD 760 million by 2036 as healthcare facilities continue prioritizing contamination control, sterile compounding, and infusion safety programs.
Why Is the Closed IV Spikes Market Growing?

Key Growth Drivers

• Safe infusion practices continue strengthening across hospitals, pharmacies, and outpatient facilities worldwide.
• Increasing oncology drug preparation is expanding demand for contamination-resistant transfer systems.
• Hospitals are steadily adopting closed transfer devices to reduce medication exposure and leakage risks.
• Infection prevention standards and medication safety protocols continue supporting market expansion.
• Growth in sterile compounding services is increasing the need for reliable closed fluid transfer products.

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/15411

Expert Analyst Perspective

Shambhu Nath Jha, Senior Analyst at Fact.MR, commented:
"Closed IV spikes are becoming an important part of safe infusion practice. Healthcare providers continue adopting closed transfer devices that reduce contamination risk and improve medication handling. Growing demand for oncology infusion and sterile compounding will support long-term market growth."

Which Spike Type Leads the Closed IV Spikes Market?
Closed Spikes Lead with 35.0% Market Share

Closed Spikes are expected to account for 35.0% of the market in 2026, making them the leading spike type segment.

Their popularity stems from their ability to minimize fluid exposure, maintain sterile transfer pathways, and reduce leakage during medication preparation and administration. Hospitals and infusion centers increasingly prefer these systems to strengthen infection-control measures.

Spike Type Highlights

• Closed Spikes: 35.0% share in 2026
• Reduced contamination risk during fluid transfer
• Improved sterile handling of medications
• Growing use in hospital pharmacies and infusion centers

Which Safety Feature Sees the Highest Adoption?
Needle-Free Systems Capture 33.0% Share
Needle-Free Systems are projected to represent 33.0% of market demand in 2026.

Healthcare providers continue adopting needle-free technologies to reduce occupational exposure risks, improve staff safety, and prevent accidental needlestick injuries. Their compatibility with existing infusion systems further supports widespread adoption.

Safety Feature Highlights

• Needle-Free Systems: 33.0% share in 2026
• Reduced needlestick injury risk
• Improved healthcare worker protection
• Enhanced compliance with safety guidelines

Gain Full Access to Market Forecasts and Key Drivers: https://www.factmr.com/report/closed-iv-spikes-market

Which Fluid Type Generates the Greatest Demand?
IV Fluids Account for 39.0% of Market Revenue
IV Fluids are expected to hold 39.0% market share in 2026, making them the largest fluid category.

Because IV fluids are administered across virtually every healthcare setting, demand for sterile transfer solutions remains consistently high. Closed IV spikes help maintain fluid integrity while minimizing contamination during preparation and administration.

Fluid Type Highlights

• IV Fluids: 39.0% share in 2026
• Extensive use across acute and chronic care settings
• Continuous demand from hospitals and clinics
• Strong alignment with infusion safety protocols

Which End User Dominates the Market?
Hospitals Hold 58.0% Share
Hospitals are projected to account for 58.0% of market revenue in 2026, making them the largest end-user segment.

Hospitals perform the majority of infusion procedures, oncology treatments, and sterile compounding activities. As healthcare facilities strengthen medication safety programs, adoption of closed transfer technologies continues to accelerate.

End-User Highlights
• Hospitals: 58.0% share in 2026
• Highest volume of infusion procedures
• Strong infection-prevention requirements
• Growing replacement of conventional transfer products
Closed IV Spikes Market Dynamics

Market Drivers
• Expansion of infusion safety initiatives
• Rising oncology treatment volumes
• Increased utilization of sterile compounding services
• Adoption of closed transfer technologies
• Strengthening infection prevention standards

Market Restraints
• Higher product costs compared with conventional IV spikes
• Budget constraints in smaller healthcare facilities
• Price sensitivity across emerging markets
• Procurement-related adoption delays

Key Market Trends
• Expansion of needle-free transfer technologies
• Growth in oncology-focused infusion safety solutions
• Increasing compatibility across IV container formats
• Greater use of closed systems in compounding pharmacies
• Enhanced focus on contamination prevention and medication safety

Where Are Future Growth Opportunities Emerging?
High-Growth Opportunity Areas
• Oncology Pharmacies
o Growing cancer treatment volumes continue increasing demand for safe drug preparation systems.
• Compounding Pharmacies
o Sterile compounding growth is supporting adoption of contamination-control technologies.
• Home Infusion Services
o Expanding home-based infusion therapy programs are creating demand for safer medication transfer systems.
• Ambulatory Surgery Centers
o Rising outpatient procedure volumes are increasing demand for workflow-efficient infusion products.
• Emerging Healthcare Markets
o Expanding healthcare infrastructure and infusion therapy access are creating long-term growth opportunities.

Regional and Country Outlook

Country-Wise CAGR Forecasts (2026-2036)
• United States: 8.9%
• Germany: 8.6%
• Japan: 8.4%
• China: 8.2%
• South Korea: 8.0%

United States
The United States is projected to achieve the highest growth among major markets, registering an 8.9% CAGR through 2036. Continuous investment in infusion safety programs, rising oncology treatment volumes, and widespread adoption of closed transfer devices are supporting market expansion.

Germany
Germany is expected to expand at 8.6% CAGR as hospitals and compounding pharmacies increasingly implement closed fluid-transfer systems. Strict medication-handling protocols and healthcare quality initiatives continue driving demand.

Japan
Japan is forecast to grow at 8.4% CAGR, supported by healthcare quality improvements, expanding infusion safety programs, and modernization of medication handling practices.

China
China is projected to record 8.2% CAGR due to growing investment in hospital infrastructure, expanding oncology services, and rising awareness of contamination-control practices.

South Korea
South Korea is expected to achieve 8.0% CAGR through 2036, supported by increased oncology care capacity, infusion safety initiatives, and broader healthcare investments.

Competitive Landscape

Leading Companies in the Closed IV Spikes Market
• B. Braun - Extensive infusion therapy and IV fluid portfolio
• ICU Medical - Strong closed transfer and medication safety technologies
• Fresenius Kabi - Global infusion and injectable therapy specialist
• CODAN - Specialized spike and fluid administration systems
• Vygon - Advanced sterile transfer and infusion solutions
• JMS Co., Ltd. - Developer of NEOSHIELDTM closed system drug transfer technologies

The competitive landscape is increasingly focused on contamination prevention, medication safety, product compatibility, and clinical performance.

Manufacturers are investing in next-generation closed transfer technologies that reduce leakage, improve sterile handling, and support compliance with healthcare guidelines. Companies with broad infusion portfolios, strong distribution networks, and hospital partnerships are expected to maintain leadership positions through 2036.

Discover the Latest Insights in the Healthcare Industry: https://www.factmr.com/industry/healthcare

FAQ: Closed IV Spikes Market
What is the projected value of the Closed IV Spikes Market by 2036?
The Closed IV Spikes Market is projected to reach USD 760 million by 2036, growing from USD 335 million in 2026.

What is the expected CAGR of the Closed IV Spikes Market?
The Closed IV Spikes Market is forecast to grow at a CAGR of 8.5% during the 2026-2036 forecast period.

Which spike type holds the largest market share?
Closed Spikes are expected to hold the leading position with a 35.0% market share in 2026 because they reduce contamination risk during fluid transfer.

Which safety feature leads the market?
Needle-Free Systems are projected to account for 33.0% of market demand in 2026 due to their ability to improve healthcare worker safety and reduce needlestick injuries.

Which fluid type generates the highest demand?
IV Fluids represent the largest fluid segment, accounting for 39.0% of market revenue in 2026.

Which end-user segment dominates the Closed IV Spikes Market?
Hospitals are expected to account for 58.0% of market revenue in 2026 because they perform the highest number of infusion procedures.

Which companies are key players in the Closed IV Spikes Market?
Key companies operating in the Closed IV Spikes Market include B. Braun, ICU Medical, Fresenius Kabi, CODAN, Vygon, and JMS Co., Ltd.

Top Trending Reports:

Closed-Loop Centesis Systems Market: https://www.factmr.com/report/closed-loop-centesis-systems-market
Closed-Loop Enteral Feeding Sensors Market: https://www.factmr.com/report/closed-loop-enteral-feeding-sensors-market
Closed Blood Sampling Systems Market: https://www.factmr.com/report/4002/closed-blood-sampling-systems-market
IV Bag and Tubing Recycling Market: https://www.factmr.com/report/iv-bag-and-tubing-recycling-market

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com

About Fact.MR
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

This release was published on openPR.